MedTrace Logo

Rosuvastatin/Amlodipine vs Atorvastatin/Amlodipine in Hypertension Patient With Dyslipidemia

NCT03951207 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 259

Last updated 2022-10-12

No results posted yet for this study

Summary

This study is to Compare the Efficacy and Safety of Rosuvastatin/Amlodipine Combination Therapy Versus Atorvastatin/Amlodipine Combination Therapy in Hypertension patient with Dyslipidemia

Conditions

Interventions

DRUG

Rosuampin 10/5mg

Rosuvastatin 10mg/Amlodipine 5mg qd for 8 weeks

DRUG

Rosuampin 20/5mg

Rosuampin 20/5mg qd for 8 weeks

DRUG

Amlodipine/Atorvastatin 5/20mg

Amlodipine/Atorvastatin 5/20mg qd for 8 weeks

Sponsors & Collaborators

  • Yuhan Corporation

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-30
Primary Completion
2021-09-29
Completion
2021-09-29

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03951207 on ClinicalTrials.gov